News NICE recommends Amgen’s melanoma treatment after price cut Drug only approved when systemic immunotherapies are not suitable
News Imbruvica, Opdivo and Praluent gain approvals for Scotland’s... Sanofi steals a march on rivals Amgen
Articles Digital health round-up - skin cancer, vocal biomarkers and ... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News Inaugural UK melanoma patient conference bridges doctor-pati... A total of 250 delegates including experts in the field and patients attended the event.
News AbbVie's migraine drug cleared for migraine attacks on NHS AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
